Page 26 - Read Online

Page 150 Eitan et al. Extracell Vesicles Circ Nucleic Acids 2023;4:133-150 https://dx.doi.org/10.20517/evcna.2023.13

Proteomics 2019;19:e1800167. DOI PubMed PMC
40. Valencia K, Montuenga LM. Exosomes in liquid biopsy: the nanometric world in the pursuit of precision oncology. Cancers (Basel)
2021;13:2147. DOI PubMed PMC
41. Willms E, Cabañas C, Mäger I, Wood MJA, Vader P. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and
diverse functions in cancer progression. Front Immunol 2018;9:738. DOI PubMed PMC
42. Strittmatter SM, Vartanian T, Fishman MC. GAP-43 as a plasticity protein in neuronal form and repair. J Neurobiol 1992;23:507-20.
DOI PubMed
43. Zhang B, Xue H, Wang W, et al. Comparative proteomic analysis of the brain and colon in three rat models of irritable bowel
syndrome. Proteome Sci 2020;18:1. DOI PubMed PMC
44. Brennan K, Martin K, FitzGerald SP, et al. A comparison of methods for the isolation and separation of extracellular vesicles from
protein and lipid particles in human serum. Sci Rep 2020;10:1039. DOI PubMed PMC
45. Sun Y, Saito K, Saito Y. Lipid profile characterization and lipoprotein comparison of extracellular vesicles from human plasma and
serum. Metabolites 2019;9:259. DOI PubMed PMC
46. Palviainen M, Saraswat M, Varga Z, et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo-
Implications for biomarker discovery. PLoS One 2020;15:e0236439. DOI PubMed PMC
47. Zhou R, Chen KK, Zhang J, et al. The decade of exosomal long RNA species: an emerging cancer antagonist. Mol Cancer 2018;17:75.
DOI PubMed PMC
48. FDA. Bioanalytical Method Validation: Guidance for Industry 2018. Available from: https://www.fda.gov/files/drugs/published/
Bioanalytical-Method-Validation-Guidance-for-Industry.pdf [Last accessed on 28 Mar 2023].
49. Winston CN, Goetzl EJ, Akers JC, et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived
blood exosome protein profile. Alzheimers Dement (Amst) 2016;3:63-72. DOI PubMed PMC
50. Eren E, Hunt JFV, Shardell M, et al. Extracellular vesicle biomarkers of Alzheimer’s disease associated with sub-clinical cognitive
decline in late middle age. Alzheimers Dement 2020;16:1293-304. DOI PubMed PMC
51. Lleó A, Núñez-Llaves R, Alcolea D, et al. Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer’s
disease cerebrospinal fluid. Mol Cell Proteomics 2019;18:546-60. DOI PubMed PMC
52. Korkut C, Li Y, Koles K, et al. Regulation of postsynaptic retrograde signaling by presynaptic exosome release. Neuron 2013;77:1039-
46. DOI PubMed PMC
53. Öhrfelt A, Brinkmalm A, Dumurgier J, et al. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's
disease. Alzheimers Res Ther 2016;8:41. DOI PubMed PMC
54. Eren E, Leoutsakos JM, Troncoso J, Lyketsos CG, Oh ES, Kapogiannis D. Neuronal-derived EV biomarkers track cognitive decline in
Alzheimer’s disease. Cells 2022;11:436. DOI PubMed PMC
55. Haynes WA, Vallania F, Liu C, et al. Empowering multi-cohort gene expression analysis to increase reproducibility. Pac Symp
Biocomput 2017;22:144-53. DOI PubMed PMC
56. Mattsson-Carlgren N, Palmqvist S, Blennow K, Hansson O. Increasing the reproducibility of fluid biomarker studies in
neurodegenerative studies. Nat Commun 2020;11:6252. DOI PubMed PMC
57. Bæk R, Søndergaard EK, Varming K, Jørgensen MM. The impact of various preanalytical treatments on the phenotype of small
extracellular vesicles in blood analyzed by protein microarray. J Immunol Methods 2016;438:11-20. DOI PubMed
58. Binderup HG, Madsen JS, Heegaard NHH, Houlind K, Andersen RF, Brasen CL. Quantification of microRNA levels in plasma -
Impact of preanalytical and analytical conditions. PLoS One 2018;13:e0201069. DOI PubMed PMC
59. Jamaly S, Ramberg C, Olsen R, et al. Impact of preanalytical conditions on plasma concentration and size distribution of extracellular
vesicles using Nanoparticle Tracking Analysis. Sci Rep 2018;8:17216. DOI PubMed PMC